Characteristics of Patients With a Complete Response Treated With Dabrafenib + Trametinib Combination Therapy: Findings From Pooled COMBI-d and COMBI-v 5-Year Analysis
Year: 2020
Type: article
Abstract: not available.
Authors: Caroline Robert, Jean Grob, Daniil Stroyakovskiy, Boguslawa Karaszewska, Axel Hauschild, Evgeny Levchenko, Vanna Sileni, Jacob Schachter, Claus Garbe, Igor Bondarenko, Paul Nathan, Antoni Ribas, Michael Davies, Keith Flaherty, Paul Burgess, Monique Tan, Eduard Gasal, Dirk Schadendorf, Georgina Long
Institutions: Institut Gustave Roussy, Aix-Marseille Université, Moscow City Oncology Hospital №62, University Hospital Schleswig-Holstein, Institute of Oncology NN Petrov, Istituto Oncologico Veneto, Tel Aviv University, Sheba Medical Center, University of Tübingen, Dnipro State Medical University, Mount Vernon Hospital, Mount Vernon Cancer Centre, University of California, Los Angeles, The University of Texas MD Anderson Cancer Center, Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Novartis (Switzerland), Essen University Hospital, Deutsches Konsortium für Translationale Krebsforschung, The University of Sydney, Royal North Shore Hospital, Melanoma Institute Australia
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W3106099381